Effects of vandetanib on lung adenocarcinoma cells harboring epidermal growth factor receptor T790M mutation in vivo

DOI IR Web Site 17 References
  • Ichihara Eiki
    Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
  • Ohashi Kadoaki
    Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
  • Takigawa Nagio
    Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
  • Osawa Masahiro
    Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
  • Ogino Atsuko
    Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
  • Tanimoto Mitsune
    Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
  • Kiura Katsuyuki
    Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences

Bibliographic Information

Other Title
  • 生体内におけるＥＧＦＲ　Ｔ７９０Ｍ遺伝子変異を持つ肺腺癌細胞に対するバンデタニブの効果
  • 平成21年度岡山医学会賞(山田賞)受賞論文 生体内におけるEGFR T790M遺伝子変異を持つ肺腺癌細胞に対するバンデタニブの効果
  • ヘイセイ 21ネンド オカヤマ イガッカイショウ ヤマダショウ ジュショウ ロンブン セイタイナイ ニ オケル EGFR T790M イデンシ ヘンイ オ モツ ハイセンガン サイボウ ニ タイスル バンデタニブ ノ コウカ

Search this article

Journal

References(17)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top